Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

61.23 -0.31 (-0.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,745,191
Open 61.29
Bid (Size) 61.23 (200)
Ask (Size) 61.60 (1,300)
Prev. Close 61.54
Today's Range 60.82 - 63.89
52wk Range 54.11 - 89.98
Shares Outstanding 384,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Reasons Investors Love DexCom (DXCM)
Over the last six months, DexCom’s shares have sunk to $62.07, producing a disappointing 6.4% loss - a stark contrast to the S&P 500’s 5.1% gain. This may ha... 
Via StockStory
Topics Stocks
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill

Performance

YTD
-8.0%
-8.0%
1 Month
-7.7%
-7.7%
3 Month
-12.2%
-12.2%
6 Month
-6.4%
-6.4%
1 Year
-11.6%
-11.6%

More News

Read More
News headline image
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
DexCom Inc (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy ↗
Via Chartmill
DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity ↗
Via Chartmill
DexCom Inc (NASDAQ:DXCM): A Prime Example of Growth at a Reasonable Price ↗
Via Chartmill
News headline image
DexCom (DXCM) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
DexCom (DXCM) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
Via MarketMinute
Topics Economy
News headline image
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
2 Growth Stocks with All-Star Potential and 1 That Underwhelm
Via StockStory
Topics Artificial Intelligence
News headline image
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government Stocks
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds
Via StockStory
News headline image
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Via StockStory
News headline image
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
Via The Motley Fool
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
From DexCom, Inc.
Via Business Wire
News headline image
2 Growth Stocks to Hold for the Next Decade ↗
Via The Motley Fool
Topics World Trade
News headline image
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
Via StockStory
Topics Economy

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 61.23
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 04/16/26 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 23.56B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 24B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.